FDA Requires More COVID Vaccine Trials Before Wider Approval

The FDA's decision on COVID-19 vaccine updates has sparked a debate. The agency will continue approving updated vaccines for those over 65 and high-risk individuals, but further clinical trials are needed for wider use. This decision has significant implications for younger, healthy Americans. Dr. Celine Gounder, a medical expert, explains that this approach is more evidence-based, but also points out the lack of transparency in the decision-making process. "Normally, this would involve a meta-analysis or systematic review," she explains, highlighting the absence of such a comprehensive review in this case. The lack of transparency and the limited availability of updated boosters for younger, healthy individuals raise concerns among the public.